Xie Lixin, Liu Youning, Xiao Yueyong, Tian Qing, Fan Baoxing, Zhao Hong, Chen Weijun
Department of Respiratory Medicine, Chinese PLA General Hospital, 28 Fuxing Rd, Beijing 100853, Peoples Republic of China.
Chest. 2005 Jun;127(6):2119-24. doi: 10.1378/chest.127.6.2119.
To follow-up on the changes in lung function and lung radiographic pictures of severe acute respiratory syndrome (SARS) patients discharged from Xiaotangshan Hospital in Beijing (by regularly receiving examination), and to analyze retrospectively the treatment strategy in these patients.
Surviving SARS patients were seen at least twice within 3 months after discharge and underwent SARS-associated coronavirus (SARS-CoV) IgG antibody testing, pulmonary function testing, and chest radiography and/or high-resolution CT (HRCT) examinations at Chinese PLA General Hospital. The treatments received at Xiaotangshan Hospital were analyzed retrospectively and were correlated to later status.
Positive SARS-Co virus IgG antibody results were seen in 208 of 258 patients, with 21.3% (55 of 258 patients) still having a pulmonary diffusion abnormality (D(LCO) < 80% of predicted). By comparing the 155 survivors with positive SARS-CoV IgG antibody results and D(LCO) > or = 80% predicted with the 50 patients with negative SARS-CoV IgG results, we found that 53 patients with positive SARS-CoV IgG results and a lung diffusion abnormality had endured a much longer course of fever and received larger doses of glucocorticoid, as well as higher ratios of oxygen inhalation and noninvasive ventilation treatment. For these patients, 51 of 53 patients with positive SARS-CoV IgG results and a lung diffusion abnormality underwent pulmonary function testing after approximately 1 month. D(LCO) improved in 80.4% of patients (41 of 51 patients). Of the patients with a lung diffusion abnormality, 40 of 51 patients showed lung fibrotic changes in the lung image examination and 22 patients (55%) showed improvement in lung fibrotic changes 1 month later.
These findings suggest that lung fibrotic changes caused by SARS disease occurred mostly in severely sick patients and may be self-rehabilitated. D(LCO) scores might be more sensitive than HRCT when evaluating lung fibrotic changes.
对北京小汤山医院出院的严重急性呼吸综合征(SARS)患者的肺功能及肺部影像学变化进行随访(定期接受检查),并对这些患者的治疗策略进行回顾性分析。
存活的SARS患者在出院后3个月内至少接受两次复诊,并在中国人民解放军总医院进行SARS相关冠状病毒(SARS-CoV)IgG抗体检测、肺功能检测以及胸部X线摄影和/或高分辨率CT(HRCT)检查。对小汤山医院给予的治疗进行回顾性分析,并与后期情况相关联。
258例患者中有208例SARS-CoV IgG抗体结果呈阳性,21.3%(258例患者中的55例)仍存在肺弥散功能异常(D(LCO)<预测值的80%)。通过将155例SARS-CoV IgG抗体结果呈阳性且D(LCO)≥预测值80%的幸存者与50例SARS-CoV IgG结果呈阴性的患者进行比较,我们发现53例SARS-CoV IgG结果呈阳性且存在肺弥散功能异常的患者发热病程更长,接受了更大剂量的糖皮质激素治疗,以及更高比例的吸氧和无创通气治疗。对于这些患者,53例SARS-CoV IgG结果呈阳性且存在肺弥散功能异常的患者中有51例在大约1个月后进行了肺功能检测。80.4%的患者(51例患者中的41例)D(LCO)有所改善。在存在肺弥散功能异常的患者中,51例患者中有40例在肺部影像学检查中出现肺纤维化改变,22例患者(55%)在1个月后肺纤维化改变有所改善。
这些发现表明,SARS疾病引起的肺纤维化改变大多发生在重症患者中,且可能会自行恢复。在评估肺纤维化改变时,D(LCO)评分可能比HRCT更敏感。